SELLAS Life Sciences Announces IND Acceptance for First Clinical Trial of GPS in China
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/ XtalPi Inc., an Artificial Intelligence (AI) drug discovery and development technology company, is presenting virtually at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13, 2021 at 12:10 PM ET.
The live webcast with XtalPi Chief Strategy Officer, Dr. Alan Jiang, will be accessible at: https://jpmorgan.metameetings.net/events/healthcare21/sessions/35249-xtalpi-inc/webcast
XtalPi is known for its Intelligent Digital Drug Discovery and Development (ID4) platform that addresses key drug properties and research challenges throughout the R&D process, from drug discovery to drug solid state development. By integrating quantum physics, artificial intelligence, and cloud high-performance computing, XtalPi has developed a series of
SELLAS Strengthens Year-End Balance Sheet with Addition of Approximately $30 5 Million
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.